Randomized trial · 2018

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.

Devinsky O, Patel AD, Thiele EA, Wong MH, Appleton R, Harden CL, Greenwood S, Morrison G, Sommerville K, GWPCARE1 Part A Study Group.

Study design
Randomized trial
Population / model
Human
Published
2018-03-14
Journal
Neurology

From the author abstract

“Thirty-four patients were randomized (10, 8, and 9 to the 5, 10, and 20 mg/kg/d CBD groups, and 7 to placebo); 32 …”

A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.

Outcome summaries · provisional

Selected source sets; evidence confidence remains ungraded.

CBD and convulsive seizures in Dravet syndrome →

Citation and indexing details

PMID 29540584 · PMC5890607

Publication types: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Topic tags: Epilepsy; Safety & interactions

Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.